RxDoctor Payments Data

Michael Brackman, DO

Family Medicine · Pinehurst, NCNPI 1194045948

Payments from drug & device makers

$232in general payments, 2019–2025

Across 14 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$43
  • Genentech USA, Inc.$30
  • Boehringer Ingelheim$30
  • Novo Nordisk$26
  • AbbVie$24
  • Valeritas, Inc.$24
  • plus $54 from 3 others

What the payments were for

  • Food & beverage$232100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$232 in reported general payments places this provider in the 45th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$281,773
Medicare patients
959
Services billed
9,933

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin309$338,043
EliquisApixaban189$184,136
TrulicityDulaglutide109$145,514
OzempicSemaglutide96$123,323
MounjaroTirzepatide71$74,223
XareltoRivaroxaban42$42,692
JanuviaSitagliptin Phosphate33$34,845
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$26,824
FarxigaDapagliflozin Propanediol27$24,749
LinzessLinaclotide23$16,416
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$13,310
Breo ElliptaFluticasone/Vilanterol23$12,266
RybelsusSemaglutide13$12,113
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$11,338
MyrbetriqMirabegron21$10,632

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$30$338,043309 claims
PfizerEliquis$20$184,136189 claims
Novo NordiskOzempic, Rybelsus$26$135,436109 claims
AbbVieLinzess$24$16,41623 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Pinehurst

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →